Androgen Receptor Inhibitor for Prostate Cancer
Created 3 months ago by marykudro

Enzalutamide is specifically available as an androgen receptor inhibitor for the treatment of patients with metastatic castration-resistant prostate cancer who have been previously treated with docetaxel. The enzalutamide 40 mg price in India ranges from 70000 INR to 80000 INR for a monthly therapy. Enzalutamide is supplied as a capsule in order to be administered orally. The recommended dose of enzalutamide is 160 mg (four 40 mg capsules) administered by mouth once daily. Enzalutamide is recommended to be taken either with/without food. The capsules need to be gulped whole.